Articles published by Nkarta, Inc.

From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights
March 26, 2025
From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2
December 05, 2024
From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 13, 2024
From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX


From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
December 09, 2023
From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX

From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX


From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX


Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX101 NK Cell Therapy Program
June 26, 2023
From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX


From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX


Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
March 16, 2023
From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX


From Nkarta, Inc.
Via GlobeNewswire
Tickers
NKTX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.